About us

"AlphaMol does now what patients need next"

AlphaMol attracts leading scientists in the areas of both biological computing and pharmaceutical sciences to join the team. We develop cutting-edge bio-technologies to substantially speed up modern drug discovery. We aim at challenging essential diseases in human health.

Shuguang Yuan

Chief Executive Officer
PhD in EPFL, KULeuven and Polish Academy of Sciences. Master in Shanghai Institute of Organic Chemistry, CAS.

Horst Vogel

Chief BioTech Officer
Emeritus professor in Swiss Federal Institute of Technology (EPFL), Lausanne. Member of the Swiss Academy of Sciences.

Shouguo Wang

Chief Medchem Officer
Postdoc in EPFL, Switzerland. PhD in Shanghai Institute of Organic Chemistry, CAS. 

Zhenquan Hu

Senior Computational Biologist
Phd in University of Basel, Switzerland. Master in Shanghai Institute of Organic Chemistry, CAS. 

Qing Pan

Senior Scientist in Biochemistry
PhD in University of Hong Kong,China.

Jixing Liu

Senior Scientist in AI Drug Discovery
Master in Southern Medical University,China.

Marc Xu

Scientist in AI Drug Discovery
Master in University of Paris, France.

Yongyin Chen

Scientist in Medchem
Master in Imperial College London, UK. 

Nathan Chen

CEO Assistant
Master in Swiss Hotel Management School, Switzerland.